drugset / Trial / NCT01097876

A Study To Evaluate The Safety, Tolerability And Plasma Drug Levels Of PF-04447943 When Administered With Donepezil To Healthy Volunteer Subjects

NCT01097876

Phase 1 Completed 24 enrolled Pfizer
RandomizedCrossoverDouble-blind

Summary

The purpose of this study is to evaluate the safety and tolerability of PF-04447943, before and after multiple doses of donepezil in healthy volunteers. Evaluate the plasma drug levels of both PF-04447943 and donepezil.

Timeline

Start
2010-04
Primary completion
2010-07
Completion
2010-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Donepezil Small molecule 10 mg
Subject EDELINONTRINE Small molecule 25 mg

Indications

No indication recorded.